How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...

Suite au départ d'Amélie de Montchalin pour présider la Cour des comptes, David Amiel, ministre délégué chargé de la Fonction publique et de la Réforme de l’État, a été nommé ce 22 février ministre de ...

Avez-vous bien suivi l'actualité, dans la perspective de votre concours ou examen professionnel ? Faites le test avec ce quiz. Police municipale : le cadre d’emplois des chefs de service en 10 ...

L’emploi dans la fonction publique est soutenu par le recrutement de contractuels Selon l’Insee, en cumulé dans les trois fonctions publiques, l’emploi progresse de + 0,6 % en 2024. Les 35 900 ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

Another day, another AI mega raise. Ricursive Intelligence, a frontier AI lab, announced on Monday that it has raised $300 million in a Series A round of funding at a $4 billion valuation. Notably, ...